Understanding which of these mechanisms, or what combination, contributes to modifying tissue-specific distribution of FAT1 will require developing cellular or animal models adequately reproducing FSHD mechanisms and mimicking in vitro key steps of muscle shape development. This evidence concerns the gene FAT1 and facioscapulohumeral muscular dystrophy.